Atlas Trials

Wet Macular Degeneration Study to Compare Ranibizumab or Bevacizumab to Aflibercept

Clinical trial NCT01617148 · COMPLETED

Trial details

NCT number
NCT01617148
Sponsor
Rishi Singh
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Exudative Macular Degeneration
Start date
2012-06-01
Primary completion
2013-12-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.